金吾财讯 | 轩竹生物-B(02575)再起升势，截至发稿，涨5.2%，报62.7港元，成交额2055万港元。需要注意的是该股于10月16日盘中最低点23.82港元至今日涨幅超1.6倍。消息面上，日前，2025年欧洲肿瘤内科学会(ESMO)年会正式召开。作为全球最具学术影响力的肿瘤学盛会之一，ESMO向来是创新药企业披露核心品种重磅临床数据的重要平台，各大药企借此不仅能提升自身知名度与行业影响力，更可拓展合作机遇。港股上市仅两周的轩竹生物，此次便在ESMO大会披露吡洛西利一线治疗临床III期(BRIGHT-3)研究数据，展现出良好的疗效性和安全优势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.